Our name changed. Our mission continues.
illustration of a bullhorn

  MGH Institute of Health Professions is now Mass General Brigham University of Health Professions. Learn more.

 

Karen Chenausky is an associate professor and director of the Speech in Autism and Neurodevelopmental Disorders (SPAN) Lab at Mass General Brigham University. She teaches graduate courses on pediatric speech sound disorders and autism. Her research seeks to understand why so many children with genetic and neurodevelopment disorders do not acquire spoken language on their own, how we can identify these children earlier, and how we can maximize their communicative potential. 

Dr. Chenausky has worked as a speech scientist performing acoustic analyses of typical, accented, dysarthric, and developing speech. She has also worked clinically in private practice and for local school districts as a speech pathologist, running social skills groups with verbal children and teens with autism and related disorders. Her work has been supported by the National Institutes of Health, the American Speech-Language-Hearing Foundation, Autism Science Foundation, Autism Speaks, Simons Searchlight, and the Tufts Clinical and Translational Science Institute. 

  • SB, Linguistics and Philosophy, MIT
  • MA, Linguistics, University of Connecticut
  • MS, Speech Pathology, Boston University
  • PhD, Speech, Language, and Hearing Sciences, Boston University

Dr. Chenausky employs perceptual, acoustic, and kinematic methods to study spoken language development in children with communication disorders. 

Dr. Chenausky has published numerous papers - some titles are highlighted below. You can view a complete listing of Dr. Chenausky's publications on Google Scholar or in her CV. 

 

Motor speech impairment predicts expressive language in minimally verbal, but not low verbal, individuals with autism spectrum disorder. Autism and Developmental Language Impairment 

Factor analysis of signs of childhood apraxia of speech. Journal of Communication Disorders. 

A modeling-guided case study of disordered speech in minimally verbal children with autism spectrum disorder. 

Review of methods for conducting speech research with minimally verbal individuals with ASD. Augmentative and Alternative Communication. 

Importance of deep speech phenotyping in neurodevelopmental and genetic disorders. Journal of Neurodevelopmental Disorders. 

 

See Google Scholar profile 

In addition, Dr. Chenausky regularly presents at conferences and industry events. Please see her CV for a complete list of presentations.

Considerations for Assessment and Treatment for Children with Complex Communication Profiles.” Oral Presentation, Apraxia-Kids Annual Conference 2025.

“Remote, In-Home Assessment of Spoken Language in Low- and Minimally Verbal Autistic Children.” Oral Presentation, International Society for Autism Research 2025

“Touch-Screen Game to Assess Categorial Perception in Minimally Verbal Children with Autism.” Oral presentation, American Speech-Language-Hearing Association 2023

“Speech Ability Affects Expressive Language in Minimally Verbal Autistic Children: Remote Replication of In-Person Findings.” Poster presentation, Gatlinburg Conference 2023

“Speech Therapy for Minimally Verbal Autistic Children: Where are we? Where can we go?” Invited presentation, NIDCD Virtual Workshop on Research Directions for Interventions to Promote Language and Communication in Minimally Verbal/Non-Speaking Individuals with Autism 2023 

Contact Information

Awards and Honors

K99/R00: Pathway to Independence Award

The K99/R00 program is designed to facilitate a timely transition from a mentored postdoctoral research position to a stable independent research position with independent NIH or other research support at an earlier stage than is currently the norm.

New Investigator Award 2022

The purpose of this award is to honor a Mass General Brigham University faculty member who has achieved distinction in the early stages of a research career by developing a program of research that is recognized for 1) creating new knowledge that significantly impacts the scientific basis of his or her field of practice, and 2) advancing the research mission of the University

2024 Rare Diseases Clinical Research Scholar